Edap Tms SA
EDAP
View Detailed Chart
2.500USD
+0.160+6.84%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
93.48MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+6.84%
5 Days
+2.04%
1 Month
+68.92%
6 Months
+5.09%
Year to Date
+13.12%
1 Year
-18.03%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-19Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Hold
Current Rating
5.767
Target Price
+146.44%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.26% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 61.93M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 570.27.
Fairly Valued
The company’s latest PE is -4.34, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 15.58M shares, decreasing 12.61% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.37.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Ticker SymbolEDAP
CompanyEdap Tms SA
CEOMr. Jean-Francois Bachelard
Websitehttps://focalone.com/fr/accueil/
Related Instruments
-0.32%
+0.66%
-0.41%
-1.01%
-0.46%
-0.19%
-0.04%
-1.02%
+1.23%
-0.64%
-1.80%
-0.27%
-2.84%
-1.19%
-0.78%
-0.30%
+0.98%
-0.72%
-1.25%
-3.23%
